fbpx Economic benefits of increased Hep C testing and treatment | NDARC - National Drug and Alcohol Research Centre

Economic benefits of increased Hep C testing and treatment

Dr Nick Scott
Resource Type: NDARC Seminars

Dr Nick Scott presented at the NDARC Webinar Series on Thursday 12 May 2022.

This webinar presented modelled estimates of the health and economic benefits of achieving hepatitis C elimination in Australia. In order to achieve elimination and realize these benefits, uptake of testing and treatment must be high among people who inject drugs. The webinar also examined a recent modelling study on the impact and cost-effectiveness of incentives to facilitate testing and treatment uptake among people who inject drugs.

 

About the speaker

Dr Nick Scott, BSc (hons), PhD (Mathematics) is the Head of Modelling & Biostatistics at the Burnet Institute, an Adjunct Senior Research Fellow at Monash University, and an NHMRC Emerging Leader Fellow. He leads a team of modellers who work across a number of infectious diseases and public health problems, particularly those impacting vulnerable populations.